Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel PDH kinase inhibitors patented at Japan Tobacco

Oct. 10, 2014

Promising initial phase I data for pramlintide/insulin fixed-dose combination

Oct. 10, 2014

Arisaph Pharmaceuticals initiates phase II study of ARI-3037-MO in hypertriglyceridemia

Oct. 9, 2014

Orphazyme prepares phase II/III trial of arimoclomol in Niemann-Pick disease type C

Oct. 8, 2014

Early clinical results for KRN-23 as potential treatment of X-linked hypophosphatemia

Oct. 7, 2014

Boehringer Ingelheim presents phase III results for linagliptin/pioglitazone FDC

Oct. 6, 2014

Prophylix Pharma to begin phase I/II trials of NAITgam for prevention of FNAIT

Oct. 6, 2014

Phase III topline results for Intarcia's ITCA-650 for type 2 diabetes

Oct. 6, 2014

FDA grants fast track designation to NKTT-120 for the treatment of sickle cell disease

Oct. 3, 2014

New AMPK activators designed at Merck & Co.

Oct. 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026